Substituted bicyclic aza-heterocycles and analogues as sirtuin modulators
AssigneeGlaxoSmithKline LLC
InventorsRebecca L. Casaubon, Radha Narayan, Christopher Oalmann, Chi B. Vu
Life of this patent
Estimating the term…
Loading patent…
AssigneeGlaxoSmithKline LLC
InventorsRebecca L. Casaubon, Radha Narayan, Christopher Oalmann, Chi B. Vu
Estimating the term…
Provided herein are novel substituted bicyclic aza-heterocycle sirtuin-modulating compounds and methods of use thereof. The sirtuin-modulating compounds may be used for increasing the lifespan of a cell, and treating and/or preventing a wide variety of diseases and disorders including, for example, diseases or disorders related to aging or stress, diabetes, obesity, neurodegenerative diseases, cardiovascular disease, blood clotting disorders, inflammation, cancer, and/or flushing as well as diseases or disorders that would benefit from increased mitochondrial activity. Also provided are compositions comprising a sirtuin-modulating compound in combination with another therapeutic agent.
A compound which is
A compound which is
Dependencies are inferred from the claim text.